Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus - Wikidata - awgldk - TriplyDB

Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus

Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus

http://www.wikidata.org/entity/Q35827846

about

Pharmacogenomics and personalized medicine: a review focused on their application in the Chinese population Association study of genetic polymorphism in ABCC4 with cyclophosphamide-induced adverse drug reactions in breast cancer patients Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with Cyclophosphamide Association of GSTT1 and GSTM1 polymorphisms with blood pressure: A Bayesian modeling of continuous data.Egyptian sweet marjoram leaves protect against genotoxicity, immunosuppression and other complications induced by cyclophosphamide in albino rats.Drug focus: Pharmacogenetic studies related to cyclophosphamide-based therapy.Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer.Genetic and epigenetic regulation of gene expression in fetal and adult human livers Unmet medical needs in lupus nephritis: solutions through evidence-based, personalized medicine Genetic markers in CYP2C19 and CYP2B6 for prediction of cyclophosphamide's 4-hydroxylation, efficacy and side effects in Chinese patients with systemic lupus erythematosus.GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group.Glutathione S-transferases: an overview in cancer research.Pharmacogenetics: implications for therapy in rheumatic diseases.Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia.Role of pharmacogenetics in busulfan/cyclophosphamide conditioning therapy prior to hematopoietic stem cell transplantation.GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis.Optimizing the use of existing therapies in lupus.Rare Cyclophosphamide-Induced Hemorrhagic Cystitis in a Chinese Population with Rheumatic Diseases Con: Cyclophosphamide for the treatment of lupus nephritis.The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy.Genetic polymorphisms of glutathione S-transferases and cytochrome P450 enzymes as susceptibility factors to systemic lupus erythematosus in southern Brazilian patients.Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia.Generalized Multifactor Dimensionality Reduction (GMDR) Analysis of Drug-Metabolizing Enzyme-Encoding Gene Polymorphisms may Predict Treatment Outcomes in Indian Breast Cancer Patients.Epistatic interactions among CYP2C19*2, CYP3A4 and GSTP1 on the cyclophosphamide therapy in lupus nephritis patients.Pharmacogenetic influence of GST polymorphisms on anthracycline-based chemotherapy responses and toxicity in breast cancer patients: a multi-analytical approach.General adverse response to cyclophosphamide in Chinese patients with systemic autoimmune diseases in recent decade—a single-center retrospective study.Pharmacogenetic association between GSTP1 genetic polymorphism and febrile neutropenia in Japanese patients with early breast cancer.Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients.Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.

P2860

Q28083875-790CC049-BC33-49F3-8DCD-35508F56E40A Q28255901-E8102E22-B1A2-4C15-90E5-A544B840193D Q28550922-242CCEE4-9DF5-4CDD-B415-68A995DDE011 Q30832426-759869C9-4EFE-48D1-84FA-B6662FC5267B Q33398772-752BBDBF-9BDC-41A2-AD5F-6B51E907B0E7 Q33646358-02CE06B9-5920-4115-B4F7-052EEF84EC4F Q34682560-44221904-4142-48EB-8761-AC6E932E3709 Q35302040-47DFA4CA-D9DA-4DD4-8759-17BB47BE2662 Q36088877-D066E37B-196C-4AE4-B698-7697C2E29A79 Q36802054-8E3058C0-8257-480C-A430-B46B7BEC171F Q36943992-CE4C4805-987A-4965-977F-F5B0D8A37583 Q37676231-416B4A22-CBB4-44FA-B154-8DCD50185875 Q37913989-F18672E3-4018-43A7-9270-4E64B682899F Q38063197-997CF32B-BCF6-4D18-AC12-6647A0752452 Q38068541-E4E43545-9E20-4A87-84F0-52B6D36CAEE4 Q38376375-E48F99D4-891E-4F38-AEEC-F714679BD036 Q38425824-06E3374B-9715-460F-A7B3-662665F3B524 Q38711151-DB4D0C10-4CDD-496E-87FF-F113211D0961 Q38837080-F84B8229-B354-4562-AE4B-671687885D45 Q38959130-434C5A61-F1DE-40B8-BFDA-555544B6BF6B Q43480092-D32D2AC2-9029-4112-8B6E-FFF1B04EA7A6 Q46518382-C3B293D8-54DB-4265-845C-30D49DDBD57A Q48113822-3FD6AD02-C394-431B-8EB8-DADE0373C464 Q49618000-4B667E4E-05FE-41A8-BB44-8E3852101860 Q50868086-196BE097-A156-4B39-BA52-2CB8F787D683 Q51125568-D6145CD6-31FD-4434-BFBE-C59AACF6A8DF Q51711572-957554BE-5A6D-4258-93D7-31C66DA188CD Q51744122-6E2AEB88-174A-4A47-927E-63BDB0B69496 Q53146007-96A20487-FBC4-407C-8E55-65782AFB643A

P2860

Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus

http://www.wikidata.org/entity/Q35827846

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Relationship of glutathione S- ...... h systemic lupus erythematosus

@ast

Relationship of glutathione S- ...... h systemic lupus erythematosus

@en

type

label

Relationship of glutathione S- ...... h systemic lupus erythematosus

@ast

Relationship of glutathione S- ...... h systemic lupus erythematosus

@en

prefLabel

Relationship of glutathione S- ...... h systemic lupus erythematosus

@ast

Relationship of glutathione S- ...... h systemic lupus erythematosus

@en

P1433

Q35827846-75FDA8DF-1645-4537-BC1C-3B07DC5C7E33

P1476

Q35827846-452EEFEB-D29A-4301-975F-FDB50E775CBA

P2093

Q35827846-09A64DF7-4A85-4904-A151-EBB3C51D6D91

Q35827846-0FC31914-51CA-49A1-835E-0C525C2EDA30

Q35827846-1A89B2BB-B042-4213-814F-49A0F44CF682

Q35827846-2F47DEA9-6FEC-4350-B6E2-892AAC0ABF49

Q35827846-6B12A957-8921-41B9-9468-92B4A73BD067

Q35827846-6C841F48-8942-4003-BACC-C65122BCF329

Q35827846-6E8309DD-8B61-4C4C-B486-29D59A7E3866

Q35827846-73D86301-6FFF-441F-BF6D-9A3BBC508F1D

Q35827846-AB2BEE93-A93A-4DCA-9C8C-0ECD7F919C85

P2860

Q35827846-05E9AAC4-9A8A-4576-A244-5EFC240090CF

Q35827846-09AAC063-FA8A-4DF5-8A05-98ECBACF41D5

Q35827846-0BF928FB-CEFD-4B7B-9872-A91C6B749C62

Q35827846-0D7977D6-7D96-4151-80F8-7B1FE5A213F8

Q35827846-243DEDE0-5833-43E2-9C03-26D1CE22095F

Q35827846-299A6F04-4CD2-492B-A9BE-49166D86D896

Q35827846-29D1AB6B-3E0C-4D47-AB99-87FE987A6BE5

Q35827846-2AD7A237-5992-49CC-BCCF-65C6D18B37E8

Q35827846-2DA0289B-1263-4EA3-951A-DB7A8475ADE3

Q35827846-32FD98E1-C7A8-4AC3-B741-FE76374E9CB7

P304

Q35827846-58938FF8-AB82-4FFA-A27F-02F77A87396E

P31

Q35827846-4D981960-17BF-476D-A02F-E4148595AB10

P356

Q35827846-4EE77A61-4720-40DB-8D25-406F849CB7F9

P407

Q35827846-1FBE2733-56B7-4405-A64F-941B0376E811

P433

Q35827846-321947C8-5ED2-47CD-9B5B-1A80B09CA8F8

P478

Q35827846-57F28E35-7986-48A1-9F81-F89BEC4B3022

P577

Q35827846-00DF309A-96C8-48CF-BCED-B14ABD36D645

P5875

Q35827846-35D48ED7-97DB-4674-A7E4-2AFC6BEE0D6C

P698

Q35827846-A252A20A-F226-4841-97B5-AED33D64898E

P932

Q35827846-B39104B0-6336-4CF5-BE63-E425EDCF5332

P356

J.1365-2125.2006.02690.X

P1433

British Journal of Clinical Pharmacology

P1476

Relationship of glutathione S- ...... h systemic lupus erythematosus

@en

P2093

Eli Chan

http://www.w3.org/2001/XMLSchema#string

Liuqin Liang

http://www.w3.org/2001/XMLSchema#string

Marjorie Romkes

http://www.w3.org/2001/XMLSchema#string

Min Huang

http://www.w3.org/2001/XMLSchema#string

Shilong Zhong

http://www.w3.org/2001/XMLSchema#string

Shu-Feng Zhou

http://www.w3.org/2001/XMLSchema#string

Wei Duan

http://www.w3.org/2001/XMLSchema#string

Xiuyan Yang

http://www.w3.org/2001/XMLSchema#string

Yixi Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily

Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion.

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms

Characterization of the human class Mu glutathione S-transferase gene cluster and the GSTM1 deletion

Differential catalytic efficiency of allelic variants of human glutathione S-transferase Pi in catalyzing the glutathione conjugation of thiotepa

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Glutathione transferases

Activity of allelic variants of Pi class human glutathione S-transferase toward chlorambucil.

Glutathione S-transferase activity influences busulfan pharmacokinetics in patients with beta thalassemia major undergoing bone marrow transplantation.

P304

457-472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2125.2006.02690.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6798418

http://www.w3.org/2001/XMLSchema#string

P698

16995867

http://www.w3.org/2001/XMLSchema#string

P932

1885164

http://www.w3.org/2001/XMLSchema#string